Uncategorized
Aerie, DSM enter collaboration agreement
Aerie Pharmaceuticals and DSM have entered into a collaborative research, development and license agreement, according to an Aerie press release.The agreement includes an option to license DSM’s bioerodible polymer implant technology in order to deliver Aerie’s compounds to treat retinal diseases, the release said.